decisionhealth Newsletters, Answer Books - 2006 Issue 3 (March)
Program_Memos / 2001 / B-01-08
Subscribe or sign in to view the full article.
Article Overview
This HCFA/Medicare program memorandum addresses a change in the effective date for a group of drug-related processing codes used for methotrexate claims. It is relevant to billing and reimbursement staff who handle Medicare carrier claims, especially those working with drug code crosswalks, claim dating, and processing edits. The article provides administrative guidance on when the revised effective date applies, what claims are affected, and the implementation timing for carriers.
Why This Topic Matters
The memo clarifies how certain methotrexate-related claims should be processed for Medicare, which affects claim routing and whether manual intervention is needed. Understanding the timing and scope of the change helps billing teams avoid processing errors and interpret historical claims correctly.
What You Will Learn
- The administrative background for a Medicare program memorandum affecting drug claim processing
- How the memo relates to claim dates, effective dates, and carrier processing workflows
- Which types of claims are impacted by the revised timing guidance
- The implementation window and administrative handling of the memorandum
Who Should Read This
- Medical coders
- Billing specialists
- Claims processors
- Revenue cycle staff
- Medicare carrier staff
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com